A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder

NCT07115329 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

164

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder

Interventions

DRUG: Zelquistinel

Sponsor

Syndeio Biosciences, Inc

Collaborators

[object Object]